
In this guide to the canine adolescent years, Christopher Pachel, DVM, DACVB, CABC (IAABC), breaks down this critical phase—from hormones to the prefrontal cortex—based on his 2026 VMX session in Orlando, Florida.

In this guide to the canine adolescent years, Christopher Pachel, DVM, DACVB, CABC (IAABC), breaks down this critical phase—from hormones to the prefrontal cortex—based on his 2026 VMX session in Orlando, Florida.

Antech Diagnostics unveils RapidRead Dental for Feline and symmetric dimethylarginine testing on its Element i+ platform.

Verdinexor tablets (Laverdia; Anivive Lifesciences) are the first oral treatment for managing lymphoma in dogs.

The cofounder of a biotech developing 3D-printing compounding technology company discusses the company's official entrance into the veterinary space, in this Q&A.

Supporting clients in keeping pets lean and up to date on vaccines and parasite prevention are simple steps veterinarians can take to help pets live longer, healthier lives, explains Brennen McKenzie, MA, MSc, VMD.

In this video, Christopher Pachel, DVM, DACVB, CABC (IAABC) emphasizes the importance finding the right solution for each patient.

A surge in influenza cases this past season coincides with acetaminophen appearing on the Pet Poison Helpline’s 2025 list of the most commonly reported toxins for cats and dogs.

Brennen McKenzie, MA, MSc, VMD, director of veterinary medicine at Loyal, a biotechnology company focusing on extending the healthy lifespan of dogs, shares medications the company is developing.

Two of the new laws give shelters more veterinary flexibility.

The product first launched in Europe in 2013.

Christopher Pachel, DVM, DACVB, CABC, explains how veterinarians can tailor medication plans for dogs with separation anxiety by matching maintenance or situational drugs to each patient’s schedule and needs.

New leadership moves, recognition, and achievement.

Thinking about age as a modifiable risk factor is reshaping how veterinarians approach care for aging dogs.

Brennen McKenzie, MA, MSc, VMD, director of veterinary medicine at Loyal, explains how energy metabolism changes as dogs age, and the health issues these changes can lead to.

Inflammatory bowel disease (IBD) may progress to feline small cell gastrointestinal (GI) lymphoma, researchers say. Texas A&M University is testing a new treatment option for the cancer.

The latest updates relating to animal care establishments and platforms.

Learn how to increase resilience in your career through intentional physical and emotional warm-ups before the start of a shift.

Christopher Pachel, DVM, DACVB, CABC (IAABC), discusses whether a separation anxiety case warrants medication in this interview with dvm360.

The latest products and innovative technology in veterinary medicine.

Zygolide by Dechra offers a generic, bioequivalent option for managing pituitary pars intermedia dysfunction in horses.

New leadership moves, recognition, and achievement.

The latest updates relating to animal care establishments and platforms.

The coping strategies that help veterinarians survive hard cases may also be the ones that wear them down over time.

Heidi Lobprise, DVM, DAVDC, discusses equipment needed for dental extractions, and why these tools are essential.

The program, planned for 2026, aims to train educators in food animal medicine and encourage more students to enter rural practice.

Smaller dogs have an increased incidence of periodontal disease, explains Heidi Lobprise, DVM, DAVDC, a veterinary dental specialist.

"I think that chronic pain is more prevalent than we actually realize...we don’t always give it the attention it deserves," says Monica Tarantino, DVM, MBA.

Virbac acquired an oral solution of methimazole, known as Felanorm in the US and Thyronorm outside the US. The drug is the first FDA-approved generic methimazole oral solution for hyperthyroidism in cats.

Gianluca Bini, DVM, MRCVS, DACVAA, shares insights on managing surgical bleeding, addressing common mistakes, and improving patient care in veterinary practices.

Purina has announced the 3 recipients of its 2026 Sponsorship for Human-Animal Bond Studies.